Chordate Medical Holding AB (OSTO:CMH) Days Sales Outstanding : 67.91 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Days Sales Outstanding?

Chordate Medical Holding AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr0.19 Mil. Chordate Medical Holding AB's Revenue for the three months ended in Mar. 2024 was kr0.26 Mil. Hence, Chordate Medical Holding AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 67.91.

The historical rank and industry rank for Chordate Medical Holding AB's Days Sales Outstanding or its related term are showing as below:

OSTO:CMH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.65 Med: 61.45 Max: 938.89
Current: 54.85

During the past 9 years, Chordate Medical Holding AB's highest Days Sales Outstanding was 938.89. The lowest was 26.65. And the median was 61.45.

OSTO:CMH's Days Sales Outstanding is ranked better than
63.52% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 64.9 vs OSTO:CMH: 54.85

Chordate Medical Holding AB's Days Sales Outstanding increased from Mar. 2023 (28.90) to Mar. 2024 (67.91).

Chordate Medical Holding AB Days Sales Outstanding Historical Data

The historical data trend for Chordate Medical Holding AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Days Sales Outstanding Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.44

90.36

61.45

403.51

43.19

Chordate Medical Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															28.90	61.30	85.84	42.12	67.91

Competitive Comparison of Chordate Medical Holding AB's Days Sales Outstanding

For the Medical Devices subindustry, Chordate Medical Holding AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Days Sales Outstanding falls into.

Chordate Medical Holding AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Chordate Medical Holding AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.02	+	0.211)	/	2 )	/	0.976	*	365
=	0.1155					/	0.976	*	365
=	43.19

Chordate Medical Holding AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.211	+	0.173)	/	2 )	/	0.258	*	365 / 4
=	0.192					/	0.258	*	365 / 4
=	67.91

Chordate Medical Holding AB (OSTO:CMH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Chordate Medical Holding AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines